Combined dendritic cell and anti-TIGIT immunotherapy potentiates adaptive NK cells against HIV-1
Abstract Natural Killer (NK) cells are promising candidates for targeting persistently infected CD4 + T cells in people with HIV-1 (PWH). However, chronicity of HIV-1 infection impairs NK cell functionality, requiring additional strategies to potentiate their cytotoxic activity. This study demonstra...
Saved in:
| Main Authors: | Ildefonso Sánchez-Cerrillo, María Agudo-Lera, Olga Popova, Ilya Tsukalov, Marta Calvet-Mirabent, Ignacio de los Santos, Lucio García-Fraile, Patricia Fuentes, Cristina Delgado-Arévalo, Juan Alcain, Nerea Sánchez-Gaona, Judith Grau-Expósito, María Lázaro-Díez, Cecilia Muñoz-Calleja, Arantzazu Alfranca, Meritxell Genescà, Julia G Prado, Vladimir Vrbanac, Alejandro Balazs, María José Buzón, María L Toribio, María A Muñoz-Fernández, Francisco Sánchez-Madrid, Enrique Martín-Gayo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2025-06-01
|
| Series: | EMBO Molecular Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s44321-025-00255-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Studying TIGIT activity against tumors through the generation of knockout mice
by: Ahmed Rishiq, et al.
Published: (2023-12-01) -
Promising New Anti‐TIGIT Agents: Stealthy Allies in Cancer Immunotherapy
by: Gatadi Srikanth, et al.
Published: (2025-04-01) -
Inhibition of TIGIT on NK cells improves their cytotoxicity and HIV reservoir eradication potential
by: Yue Wang, et al.
Published: (2025-03-01) -
Tiragolumab and TIGIT: pioneering the next era of cancer immunotherapy
by: Kosar Ghasemi, et al.
Published: (2025-06-01) -
TIGIT+ CD4+ regulatory T cells enhance PD-1 expression on CD8+ T cells and promote tumor growth in a murine ovarian cancer model
by: Fengzhen Chen, et al.
Published: (2024-12-01)